ArticleCanadian respiratory journal2022

Dexmedetomidine Attenuates LPS-Stimulated Alveolar Type II Cells' Injury through Upregulation of miR-140-3p and Partial Suppression of PD-L1 Involving Inactivating JNK-Bnip3 Pathway.

Xianfeng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.